Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 5/20 | 0.65 |
| ▸ | F2 | P00734 | 2/20 | 0.63 |
| ▸ | F10 | P00742 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | MMP2 | P08253 | 4/20 | 0.52 |
| ▸ | MMP9 | P14780 | 3/20 | 0.52 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.52 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.52 |
| ▸ | EDNRA | P25101 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4134328 | 1.00 | TYMS (0.65) | TYMSF2F10ALDH1A1MAPT | |
| SCHEMBL4134334 | 1.00 | TYMS (0.65) | TYMSF2F10ALDH1A1MAPT | |
| SCHEMBL29829755 | 1.00 | TYMS (0.65) | TYMSF2F10ALDH1A1MAPT | |
| SCHEMBL29597077 | 0.92 | F2 (0.63) | TYMSF2F10EDNRAPTGS2 | |
| SCHEMBL27578159 | 0.92 | F2 (0.63) | TYMSF2F10EDNRAPTGS2 | |
| SCHEMBL29941510 | 0.88 | TYMS (0.81) | TYMSF2F10PTGS2 | |
| SCHEMBL4325460 | 0.88 | TYMS (0.81) | TYMSF2F10PTGS2 | |
| SCHEMBL5706271 | 0.87 | TYMS (0.54) | TYMSF2EDNRA | |
| SCHEMBL6266410 | 0.87 | TYMS (0.54) | TYMSF2EDNRA | |
| SCHEMBL17351925 | 0.86 | TYMS (0.57) | TYMSF2F10EDNRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240189317-A1 | ANTIVIRAL COMPOSITIONS AND METHODS | ACADIA WOODS PARTNERS, LLC | 2024-06-13 | — | — | US | claimed |
| EP-2934555-B1 | METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS | ASTELLAS INST FOR REGENERATIVE MEDICINE (US) | 2021-09-22 | — | — | EP | claimed |
| CN-107249578-B | Method for treating envenomation and related pharmaceutical composition, system and kit | 奥菲瑞克斯股份有限公司 | 2021-01-26 | — | — | CN | claimed |
| US-20170354642-A1 | ENVENOMATION THERAPIES AND RELATED PHARMACEUTICAL COMPOSITIONS, SYSTEMS AND KITS | OPHIREX INC (US) | 2017-12-14 | — | — | US | claimed |
| EP-3220902-A2 | ENVENOMATION THERAPIES AND RELATED PHARMACEUTICAL COMPOSITIONS, SYSTEMS AND KITS | Ophirex, Inc. (US) | 2017-09-27 | — | — | EP | claimed |
| US-20250090586-A1 | METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF | ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE (US) | 2025-03-20 | — | — | US | disclosed |
| US-12076347-B2 | Methods for production of platelets from pluripotent stem cells and compositions thereof | ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE (US) | 2024-09-03 | — | — | US | disclosed |
| WO-2023086343-A1 | COMPOSITIONS AND DOSAGE FORMS FOR TOPICAL AND TRANSDERMAL DELIVERY OF ACTIVES AND METHODS OF USE | OPHIREX, INC. (US) | 2023-05-19 | — | — | WO | disclosed |
| CN-114504843-B | Preparation method of capillary open-tube chromatographic column based on metal organic framework material | 上海大学 | 2023-05-02 | — | — | CN | disclosed |
| US-20230028239-A1 | METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF | ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE (US) | 2023-01-26 | — | — | US | disclosed |
| CN-115379836-A | Early management and prevention of sepsis and sepsis-like syndrome | 奥菲瑞克斯公司 | 2022-11-22 | — | — | CN | disclosed |
| US-11400118-B2 | Methods for production of platelets from pluripotent stem cells and compositions thereof | ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE (US) | 2022-08-02 | — | — | US | disclosed |
| US-9993503-B2 | Methods for production of platelets from pluripotent stem cells and compositions thereof | ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE (US) | 2018-06-12 | — | — | US | disclosed |
| US-20170354642-A1 | ENVENOMATION THERAPIES AND RELATED PHARMACEUTICAL COMPOSITIONS, SYSTEMS AND KITS | OPHIREX INC (US) | 2017-12-14 | — | — | US | disclosed |
| EP-3220902-A2 | ENVENOMATION THERAPIES AND RELATED PHARMACEUTICAL COMPOSITIONS, SYSTEMS AND KITS | Ophirex, Inc. (US) | 2017-09-27 | — | — | EP | disclosed |
| US-20160022736-A1 | METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF | ADVANCED CELL TECHNOLOGY, INC. (US) | 2016-01-28 | — | — | US | disclosed |
| US-20150313944-A1 | METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF | OCATA THERAPEUTICS, INC. (US) | 2015-11-05 | — | — | US | disclosed |
| EP-2934555-A1 | METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF | Ocata Therapeutics, Inc. (US) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014100779-A1 | METHODS OFR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF | ADVANCED CELL TECHNOLOGY, INC. (US) | 2014-06-26 | — | — | WO | disclosed |
| WO-1996041173-A1 | NANOPARTICLES IMPRINTED WITH RECOGNITION SITES FOR TARGET MOLECULES | MARTINEX R & D INC. (CA) | 1996-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240189317-A1 | ANTIVIRAL COMPOSITIONS AND METHODS | PIKFYVE, APAF1, API5 | TYMS 690/4885F2 600/4885F10 1288/4885 |
| US-20150313944-A1 | METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF | THPO, PDGFRA, PDGFRB | TYMS 1618/4885F2 479/4885F10 299/4885 |
| US-20230028239-A1 | METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF | THPO, PDGFRA, PDGFRB | TYMS 1618/4885F2 479/4885F10 299/4885 |
| US-11400118-B2 | Methods for production of platelets from pluripotent stem cells and compositions thereof | THPO, PDGFRA, PDGFRB | TYMS 1618/4885F2 479/4885F10 299/4885 |
| US-20250090586-A1 | METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF | THPO, PDGFRA, PDGFRB | TYMS 1618/4885F2 479/4885F10 299/4885 |
| US-20170354642-A1 | ENVENOMATION THERAPIES AND RELATED PHARMACEUTICAL COMPOSITIONS, SYSTEMS AND KITS | PLA2R1, PLA2G12A, ACHE | TYMS 1475/4885F2 181/4885F10 246/4885 |
| US-20160022736-A1 | METHODS FOR PRODUCTION OF PLATELETS FROM PLURIPOTENT STEM CELLS AND COMPOSITIONS THEREOF | THPO, PDGFRA, PDGFRB | TYMS 1618/4885F2 479/4885F10 299/4885 |
| US-12076347-B2 | Methods for production of platelets from pluripotent stem cells and compositions thereof | THPO, PDGFRA, PDGFRB | TYMS 1618/4885F2 479/4885F10 299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.